A Review on Neem Nanoparticles used in Cancer Therapy

Vaishnavi Ashok Gore

doi:10.52711/2349-2988.2026.00038

Research Journal of Science and Technology

ISSN

2349-2988 (Online)
0975-4393 (Print)

Submit Article

A Review on Neem Nanoparticles used in Cancer Therapy

Author(s): Vaishnavi Ashok Gore

Email(s): vaishnavigore04042004@gmail.com

DOI: 10.52711/2349-2988.2026.00038

Address: Vaishnavi Ashok Gore
Swastyadarpan Pratishthan’s, Shantiniketan College of Pharmacy, A/P Dhotre (B.K.), Tal. Parner, Ahmednagar, Maharashtra – 414302.
*Corresponding Author

Published In: Volume - 18, Issue - 3, Year - 2026

View HTML

Purchase PDF

ABSTRACT:
In 2024, India was estimated to have 1.56 million new cancer cases and 874,404 cancer deaths, according to a study by the Indian Council of Medical Research (ICMR). In recent years, nanoparticles have drawn a lot of interest as a promising drug delivery system to address this challenge, particularly for the treatment of cancer. Nanoparticles, or particles with a size of roughly 10 to 100 nanometers, have the potential to be especially effective agents in the detection, diagnosis, and treatment of cancer because of their size and supramolecular structures. The study describes how different nanoparticles—such as liposomes, polymeric nanoparticles, dendrimers, and magnetic nanoparticles—are used for targeted drug delivery. When compared to conventional therapy, these nanoparticledrug formulations can improve the safety, pharmacokinetic profiles, and bioavailability of the administered drugs, resulting in increased therapeutic efficacy. Nanomedicine products represent an opportunity to achieve sophisticated targeting Strategies and multifunctionality. Azadirachta indica (neem), a medicinal plant with a well-documented history in Ayurvedic medicine, is a rich source of bioactive limonoids possessing potent anticancer properties. This review comprehensively examines the convergence of neem phytochemistry and nanotechnology, focusing on the green synthesis of neem-based nanoparticles (NPs) and their multifaceted mechanisms against cancer. We elaborate on the efficacy of various neem NPs, including silver, gold, zinc oxide, and polymeric NPs, in inducing apoptosis, generating reactive oxygen species (ROS), inhibiting metastasis, and modulating key oncogenic pathways. Discusses the current challenges, and presents future perspectives for the clinical translation of neem nanoparticles as a cornerstone of integrative oncology. This study explores a novel herbal drug delivery system utilizing neem nanoparticles for the targeted delivery of anticancer compounds, enhancing therapeutic efficacy.

Keywords:

Cite this article:
Vaishnavi Ashok Gore. A Review on Neem Nanoparticles used in Cancer Therapy. Research Journal of Science and Technology. 2026; 18(3):274-8. doi: 10.52711/2349-2988.2026.00038

Cite(Electronic):
Vaishnavi Ashok Gore. A Review on Neem Nanoparticles used in Cancer Therapy. Research Journal of Science and Technology. 2026; 18(3):274-8. doi: 10.52711/2349-2988.2026.00038 Available on: https://www.rjstonline.com/AbstractView.aspx?PID=2026-18-3-5

8. REFERENCES:
1. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell. 2011;144(5):646-74.
2. World Health Organization. Cancer [Internet]. 2023 [cited 2025 Oct 26]. Available from: https://www.who.int/news-room/fact-sheets/detail/cancer
3. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-49.
4. Islami F, Goding Sauer A, Miller KD, Siegel RL, Fedewa SA, Jacobs EJ, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68(1):31-54.
5. Dagogo-Jack I, Shaw AT. Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol. 2018;15(2):81-94.
6. Longley DB, Johnston PG. Molecular mechanisms of drug resistance. J Pathol. 2005;205(2):275-92.
7. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2(12):751-60.
8. Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33(9):941-51.
9. Bobo D, Robinson KJ, Islam J, Thurecht KJ, Corrie SR. Nanoparticle-based medicines: A review of FDA-approved materials and clinical trials to date. Pharm Res. 2016;33(10):2373-87.
10. Rzigalinski BA, Strobl JS. Cadmium-containing nanoparticles: perspectives on pharmacology and toxicology of quantum dots. Toxicol Appl Pharmacol. 2009;238(3):280-8.
11. Maeda H. The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul. 2001;41:189-207.
12. Bertrand N, Wu J, Xu X, Kamaly N, Farokhzad OC. Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev. 2014;66:2-25.
13. Wang AZ, Langer R, Farokhzad OC. Nanoparticle delivery of cancer drugs. Annu Rev Med. 2012;63:185-98.
14. Wilczewska AZ, Niemirowicz K, Markiewicz KH, Car H. Nanoparticles as drug delivery systems. Pharmacol Rep. 2012;64(5):1020-37.
15. Wicki A, Witzigmann D, Balasubramanian V, Huwyler J. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. J Control Release. 2015;200:138-57.
16. Borehole Y. Doxil®—the first FDA-approved nano-drug: Lessons learned. J Control Release. 2012;160(2):117-34.
17. Biswas K, Chattopadhyay I, Banerjee RK, Bandyopadhyay U. Biological activities and medicinal properties of neem (Azadirachta indica). Curr Sci. 2002;82(11):1336–45.
18. Paul R, Prasad M, Sah NK. Anticancer biology of Azadirachta indica L (neem): a mini review. Cancer Biol Ther. 2011;12(6):467–76.
19. Gupta SC, Prasad S, Reuter S, Kannappan R, Yadav VR, Ravindran J, et al. Modification of cysteine 179 of IκBα kinase by nimbolide leads to down-regulation of NF-κB-regulated cell survival and proliferative proteins and sensitization of tumor cells to chemotherapeutic agents. J Biol Chem. 2011;286(13):11337–49.
20. Nirmala MJ, Durai L, Gopakumar V, Nagarajan R. Preparation of celery essential oilbased nanoemulsion by ultrasonication and evaluation of its potential anticancer and antibacterial activity. Int J Nanomedicine. 2020;15:7651–66.
21. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2(12):751–60.
22. Mittal AK, Chisti Y, Banerjee UC. Synthesis of metallic nanoparticles using plant extracts. Biotechnol Adv. 2013;31(2):346–56.
23. Kharat SN, Mendhulkar VD. Synthesis, characterization and studies on antioxidant activity of silver nanoparticles using Elephantopus scaber leaf extract. Mater Sci Eng C Mater Biol Appl. 2016; 62:719–24.
24. Jeyaraj M, Sathishkumar G, Sivanandhan G, MubarakAli D, Rajesh M, Arun R, et al. Biogenic silver nanoparticles for cancer treatment: an experimental report. Colloids Surf B Biointerfaces. 2013; 106:86–92.
25. Vijayakumar M, Priya K, Ilavenil S, Janani B. Gold nanoparticles by using Azadirachta indica seed extract and its application in cancer therapy. J Acad Ind Res. 2016;5(3):49–54.
26. Gopinath K, Kumaraguru S, Bhakyaraj K, Mohan S, Venkatesh KS, Esakkirajan M, et al. Green synthesis of silver, gold and silver/gold bimetallic nanoparticles using the Gloriosa superba leaf extract and their antibacterial and antibiofilm activities. Microb Pathog. 2016; 101:1–11.
27. Akhtar MJ, Ahamed M, Kumar S, Khan MM, Ahmad J, Alrokayan SA. Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species. Int J Nanomedicine. 2012; 7:845–57.
28. Nagajyothi PC, Cha SJ, Yang IJ, Sreekanth TVM, Kim KJ, Shin HM. Antioxidant and antiinflammatory activities of zinc oxide nanoparticles synthesized using Polygala tenuifolia root extract. J Photochem Photobiol B. 2015; 146:10–7.
29. Das S, Das J, Samadder A, Paul A, Khuda-Bukhsh AR. Biosynthesized silver nanoparticles by ethanolic extracts of Phytolacca decandra, Gelsemium sempervirens, Hydrastis canadensis and Thuja occidentalis induce differential cytotoxicity through G2/M arrest in A375 cells. Colloids Surf B Biointerfaces. 2013; 101:325–36.
30. Sanna V, Pala N, Dessi G, Manconi P, Mariani A, Dedola S, et al. Nimbolide-loaded polymeric nanoparticles inhibit pancreatic cancer growth and metastasis. Oncotarget. 2017;8(60):102241–53.
31. Elumalai P, Gunadharini DN, Senthilkumar K, Banudevi S, Arunkumar R, Benson CS, et al. Induction of apoptosis in human breast cancer cells by nimbolide through extrinsic and intrinsic pathway. Toxicol Lett. 2015;215(2):131–42.
32. Sriram MI, Kanth SBM, Kalishwaralal K, Gurunathan S. Antitumor activity of silver nanoparticles in Dalton’s lymphoma ascites tumor model. Int J Nanomedicine. 2010; 5:753–62.
33. Karkare S, Chhipa RR, Anderson J, Liu X, Henry H, Gasilina A. Expression of nucleotide excision repair . proteins in pancreatic cancer and therapeutic potential of its inhibition. J Clin Oncol. 2019;37(4 Suppl):348.
34. Bodduluru LN, Kasala ER, Madhana RM, Barua CC. Antioxidant and anticancer activities of leaves of Azadirachta indica (Neem): a review. Free Radic Antioxid. 2015;5(2):65–75.
35. Mukherjee S, Ghosh S, Das DK, Chakraborty P, Choudhury S, Gupta P. Gold nanoparticles from neem leaf extract and its anticancer activity against hepatocarcinoma.
36. Int J Nanomedicine. 2015; 10:79–92.
37. Roy MK, Kobori M, Takenaka M, Nakahara K, Shinmoto H, Tsushida T. Antiproliferative effect on human cancer cell lines after treatment with nimbolide extracted from an edible part of the neem tree (Azadirachta indica). Phytother Res. 2007;21(3):245–50.
38. Subramani C, Bari MA, Hossain MS. Silver nanoparticles synthesized from Azadirachta indica leaf extract and its anticancer activity against Ehrlich’s ascites carcinoma. J Drug Deliv Sci Technol. 2016; 35:303–9.
39. Ahmad A, Mukherjee P, Senapati S, Mandal D, Khan MI, Kumar R, Sastry M. Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium oxysporum. Colloids Surf B Biointerfaces. 2003;28(4):313–8.
40. Patwardhan CA, Fauq A, Peterson LB, Miller C, Blagg BS, Chadli A. Gedunin inactivates the co-chaperone p23 protein causing cancer cell death by apoptosis. J Biol Chem. 2013;288(10):7313–25.
41. Baral R, Mandal I. Anti-neoplastic potential of Azadirachta indica (neem) and their nanoformulations in cancer therapy. In: Natural Products and Cancer Drug Discovery. London: IntechOpen; 2018.
42. Bhanwra S, Singh J, Khosla P. Effect of Azadirachta indica (Neem) leaf aqueous extract on paracetamol-induced liver damage in rats. Indian J Physiol Pharmacol. 2000;44(1):64–8.
43. Katoch D, Sharma A. Challenges in the development of herbal nanomedicines. In: Applications of Nanotechnology in Drug Discovery and Delivery. Florida: Apple Academic Press; 2018.
44. De Jong WH, Borm PJ. Drug delivery and nanoparticles: Applications and hazards. Int J Nanomedicine. 2008;3(2):133–49.
45. Huh AJ, Kwon YJ. Nanoantibiotics: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Control Release. 2011;156(2):128–45.
46. Danhier F, Feron O, Préat V. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release. 2010;148(2):135–46.
47. Hu CM, Zhang L. Nanoparticle-based combination therapy toward overcoming drug resistance in cancer. Biochem Pharmacol. 2012;83(8):1104–11.